Actuate Therapeutics, Inc.: H.C. Wainwright cuts target price to $10 from $15
ACTU•H.C. Wainwright cut its target price for Actuate Therapeutics to $10 from $15.
Related News

Citigroup cuts Roblox to neutral from buy
RBLX•

IHS Holding, MTN extend merger deadline to December 17, 2026
IHS•

Box Inc: Citigroup raises target price to $55 from $40
BOX•

Gaming and Leisure Properties, Inc.: Wells Fargo cuts target price to $39 from $40
GLPI•

Nakamoto amends at-the-market stock offering agreement for up to $4.99 billion
NAKA•